Moritz Kircher, MD, PhD, will join the Brigham as chief of the Division of Oncoradiology in the Department of Radiology on Dec. 1. In addition to his appointment here, he will serve as chair of the Department of Imaging and Radiology at Dana-Farber Cancer Institute (DFCI).
A renowned physician-scientist with a background in imaging at the microscopic level, Kircher brings a wealth of clinical and research knowledge. His clinical expertise lies in abdominal and pelvic imaging, focusing on the evaluation of the liver, pancreas and biliary tree (the organs and ducts that make and store bile). As a researcher, he has pioneered techniques for using nanoparticles to detect cancerous and precancerous tissue with microscopic precision.
Kircher comes to the Brigham and DFCI from Memorial Sloan Kettering Cancer Center, where he is associate vice chair for Research in the Department of Radiology. Outside the clinic and lab, he is the founding chair of the Molecular Imaging in Nanotechnology and Theranostics Interest Group of the World Molecular Imaging Society and co-editor-in-chief of the journal Nanotheranostics.
Kircher received his medical and doctorate degrees with highest honors from Humboldt University in Berlin, a medical school affiliated with Charité – Universitätsmedizin Berlin, one of Europe’s largest teaching hospitals. He presented his habilitation thesis at the Technical University of Munich. He completed his residency in diagnostic radiology at Beth Israel Deaconess Medical Center, where he was chief resident; a clinical body MRI fellowship at Stanford University in California; and his postdoctoral training in molecular imaging at Massachusetts General Hospital and Stanford University.